Public Reporting

ACO Name and Location

PremierMD ACO, LLC
3465 Galt Ocean Drive
Fort Lauderdale, FL 33308

ACO Primary Contact

Victor Toledano
(954) 561-5135

Organizational information

  • ACO Participants

Aklilu And Cobian Infectious Diseases Llc
Alan Graff MD PA
Altercare, LLC
Amit Upadhiaya DO PA
Andrew G Logan Md Pa
Angela M Rodriguez MD PA
Arturo R Logrono MD PA
Barbara Ann Scherer MD PA
Basilio Garciasellek D O P A
Behnam Birgani Do Pa
Birjis K. Alam MD PA
Blue Water Pain Solutions PA
Broward Eyecare Associates
Broward Family Medical Group LLC
Broward Oncology Associates PA
Caps Medical Management LLC
Cardiovascular Specialists of South Florida PA
Carlos A Corrales MD LLC
Carlos R Santos MD PA
Centro Medico Familiar Buen Pastor Inc
Clinique Medmanagement Group LLC
Complete Home Care Of Broward County Llc
Diab Agha Kidney and Hypertension Clinic, Inc.
Doctors Plus Medical Center Inc
Dr Jason Evans PA
Dr Sanford M. Silverman, Md Pa
Emerald Hills Medical Center Inc
Firaz R Hosein DO PA
Florida Heart Rhythm Specialists PLLC
Floyd A Osterman, Jr., MD PA
Gary Saff Pllc
George P. Azar Jr. MD PA
Geriatrics And Adult Medicine Llc
Harold S Williams MD & Associates PA
Infections Managed Inc
Infectious Disease Consultants PA
Innovative Health And Wellness Llc
Jason M Goldman MD PA
Jean Jacques Rajter, M.D. P.A.
Joel D Stein DO PA
Jose Orcasita-Ng PA
Kenneth E Bresky DO PA
Kenneth H Zelnick Md Pa
Kumar Rajagopalan MD PA
La Clinique 300 Inc
Lifetime Family Urgent Care Llc
Luis H Lugo Arrendell MD PA
Matthew C Popkin MD PA
Max-Med Clinic Inc
Midland Medical Broward Inc
Ortho Florida LLC
Palm Access Llc
Palm Beach Primary Care Associates Inc.
Palm Vascular Center Of Broward, Llc
Pompano Beach Community Medical Center Inc
Rajiv Chokshi
Richard A McLean MD PA
Robert Odell
Ronald M Tuttelman Mdpa
Rsb Dermatology Inc
Salvador Mora
Satya P Singh MD PA
Southeast Florida Hematology – Oncology Group, PA
St Johns Rehabilitation Hospital And Nursing Center Inc
St. Anne’s Nursing Center, St Anne’s Residence Inc
Sylvan Goldin Pa
The Kidney Group Of South Florida
Total Orthopaedic Care
Vanguard Medical Group LLC
Varki CancerCare Center PA
Veronica Gipps
Victor Toledano MD PA
Villa Maria Nursing & Rehabilitation Center
Wayne J M Fraser Pa
Wellcare Medical Clinic LLC
Wellness Medical Clinic And Geriatric Center Inc
Wilfred C McKenzie MD PA
William V Jensen DO PA

  • ACO participants in joint ventures between ACO professionals and hospitals:

No participants are involved in a joint venture between ACO professionals and hospitals

  • ACO governing body:

Victor Toledano, M.D., Voting Member; Victor Toledano MD PA
Joseph Vasta, Voting Member and Medicare Beneficiary Representative

William Jensen, D.O., Voting Member; William V Jensen DO PA
Scott Silverstein, D.O., Voting Member; Innovative Health And Wellness LLC
Antonio Wong, M.D., Voting Member; Doctors Plus Medical Center Inc

  • Key ACO clinical and administrative leadership:

ACO Executive: Dr. Victor Toledano
Medical Director: Dr. Victor Toledano

Compliance Official: Dr. Victor Toledano
Quality Assurance/Improvement Officer: Dr. Antonio Wong

  • Associated committees and committee leadership:

Quality Assurance and Improvement Committee: Dr. Antonio Wong, Chairman
Utilization Committee: Dr. William V. Jensen, Chairman
Compliance Committee: Dr. Victor Toledano

  • Types of ACO participants, or combinations of participants that formed the ACO:

Network of individual practices of ACO professionals


Shared Savings and Losses:

Amount of Shared Savings/Losses
  • Performance Year 1: Not in Operations
  • Agreement period beginning 2014, Performance Year 2014 – $0
  • Agreement period beginning 2014, Performance Year 2015 – $0
Shared Savings distribution
  • Agreement period beginning 2014, Performance Year 2014 – $0
  • Agreement period beginning 2014, Performance Year 2015 – $0
Payment Rule Waivers
  • No, our ACO does not use the SNF 3-Day Rule Waiver
Quality Performance Results

2015 Quality Performance Results Table

Measure number

Measure Name

2015 reporting period

performance rate

Mean performance rate (SSP-  ACOs)

ACO-1 CAHPS: Getting Timely Care, Appointments, and Information  79.59  80.61
ACO-2 CAHPS: How Well Your Providers Communicate  92.72  92.65
ACO-3 CAHPS: Patients’ Rating of Provider  93.69  91.94
ACO-4 CAHPS: Access to Specialists  84.11  83.61
ACO-5 CAHPS: Health Promotion and Education  60.13  59.06
ACO-6 CAHPS: Shared Decision Making  75.98  75.17
ACO-7 CAHPS: Health Status/Functional Status  74.44  72.30
ACO-34 CAHPS: Stewardship of Patient Resources*  27.22  26.87
ACO-8 Risk Standardized, All Condition Readmission  15.53  14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)*
 20.11  18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes*  56.46  54.60
ACO-37  All-Cause Unplanned Admissions for Patients with Heart Failure*  80.20  76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions  68.34  62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)  1.93  1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)  1.30  1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use
 47.06%  76.22%
ACO-39 Documentation of Current Medications in the Medical Record*  70.84%  84.07%
ACO-13 Falls: Screening for Future Fall Risk  33.78%  56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization  32.97%  62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults  30.16%  63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up  70.08%  75.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention  88.05%  90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan  30.11%  45.25%
ACO-19 Colorectal Cancer Screening  56.25%  60.06%
ACO-20 Breast Cancer Screening  60.38%  65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and
Follow-Up Documented
 61.22%  70.04%
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control  22.39%  20.38%
ACO-41 Diabetes: Eye Exam*  20.60%  41.05%
ACO-28 Hypertension: Controlling High Blood Pressure  74.17%  69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic  60.37%  83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)  85.19%  87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)  71.33%  77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.*= Measure required beginning Reporting Year 2015.N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A


2013-2014 Quality Performance Results Table

Measure Number Measure Name 2012 Reporting Period 2013 Reporting Period 2014 Reporting Period
PremierMD ACO Performance Rate Mean Performance of all ACO’s PremierMD ACO Performance Rate Mean Performance of all ACO’s PremierMD ACO Performance Rate Mean Performance of all ACO’s
ACO-1 Getting Timely Care, Appointments, and Information Not in operations Not in operations Not in operations Not in operations 78.27 80.13
ACO-2 How Well Your Doctors Communicate 92.87 92.39
ACO-3 Patients’ Rating of Doctor 91.9 91.58
ACO-4 Access to Specialists 83.97 83.97
ACO-5 Health Promotion and Education 60.12 58.29
ACO-6 Shared Decision Making 71.41 74.6
ACO-7 Health Status/Functional Status 69.54 71.1
ACO-8 Risk Standardized, All Condition Readmissions 15.86 15.15
ACO-9 ASC Admissions: COPD or Asthma in Older Adults 1.49 1.08
ACO-10 ASC Admission: Heart Failure 1.23 1.19
ACO-11 Percent of PCPs who qualified for EHR Incentive Payment 62.26 76.71
ACO-12 Medication Reconciliation 91.57 82.61
ACO-13 Falls: Screening for Fall Risk 25.43 45.6
ACO-14 Influenza Immunization 20.35 57.51
ACO-15 Pneumococcal Vaccination 18.6 55.03
ACO-16 Adult Weight Screening and Follow-up 76.62 66.75
ACO-17 Tobacco Use Assessment and Cessation Intervention 87.61 86.79
ACO-18 Depression Screening 21.85 39.27
ACO-19 Colorectal Cancer Screening 38.63 56.14
ACO-20 Mammography Screening 58.02 61.41
ACO-21 Proportion of Adults who had blood pressure screened in past 2 years 76.82 60.24
ACO-22  Hemoglobin A1c Control (HbA1c) (<8 percent)  71.75  N/A
ACO-23 Low Density Lipoprotein (LDL) (< 100 mg/dL) N/A  N/A
ACO-24 Blood Pressure (BP) < 140/90 75.09  N/A
ACO-25 Tobacco Non-Use 84.91  N/A
ACO-26 Aspirin Use 78.92  N/A
ACO-27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 18.82 20.35
ACO-28 Percent of beneficiaries with hypertension whose BP < 140/90 79.03 68.02
ACO-29 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl 58.61 57.29
ACO-30 Percent of beneficiaries who use Aspirin or other antithrombotic 79.3 80.79
ACO-31 Beta-Blocker Therapy for LVSD 88.64 82.71
ACO-32 Drug Therapy for Lowering LDL-Cholesterol 74.19  N/A
ACO-33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD 77.11  N/A

For more information on how to interpret scores on the above quality performance measures, see